• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      EyeWorld Weekly, June 20, 2025 - EyeWorld - 16 day(s) ago

      ➤ Preservative-free fixed-dose combination therapy for glaucoma in development ➤ Rare Pediatric Disease designation granted to investigational Stargardt gene therapy ➤ First patient dosed in genome editing program for corneal dystrophy ➤ ASCRS news and events

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        News of the week: IND approval for Phase 2/3 pivotal trial moves Stargardt gene therapy forward, FDA approves generic anti-inflammatory, resubmission for dry eye disease drug candidate, and more. Read all about it in EyeWorld Weekly https://t.co/rv6khicxN3 https://t.co/iqeqau3p3x

    • Mashup Score: 2
      Analyzing waste from IOL packaging - EyeWorld - 17 day(s) ago

      One of the authors of the recently published study “Analysis of intraocular lens packaging weight and waste,” which highlighted the differences between packaging waste of various IOLs and their paper or e-IFUs, discussed the study and the disparities in packaging across different IOL models, identifying key opportunities for reducing waste.

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        In the current issue of EyeWorld, the EyeSustain Update column focuses on analyzing waste from IOL packaging https://t.co/6tuF6D2bU7 https://t.co/yYlkwmMSYv

    • Mashup Score: 3
      Elena Barraquer, MD, selected as recipient of 2025 ASCRS Foundation Chang-Crandall Humanitarian Award - EyeWorld - 20 day(s) ago

      The ASCRS Foundation Board proudly announced its selection of Elena Barraquer, MD, for the 2025 Chang-Crandall Humanitarian Award. For many years, Dr. Barraquer has led the Elena Barraquer Foundation, a nonprofit organization that fights avoidable blindness due to cataract in developing countries.

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        At the 2025 ASCRS Annual Meeting, Elena Barraquer, MD, was honored with the ASCRS Foundation Chang-Crandall Humanitarian Award. Read about her work in EyeWorld https://t.co/KXN0THgDkB https://t.co/IXXituiYxQ

    • Mashup Score: 0
      EyeWorld Weekly, June 13, 2025 - EyeWorld - 23 day(s) ago

      ➤ Preservative-free fixed-dose combination therapy for glaucoma in development ➤ Rare Pediatric Disease designation granted to investigational Stargardt gene therapy ➤ First patient dosed in genome editing program for corneal dystrophy ➤ ASCRS news and events

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        News of the week: PF fixed-dose combination therapy for glaucoma, Rare Pediatric Disease designation for Stargardt gene therapy, first patient dosed in gene therapy program for corneal dystrophy, and more. Read all about it in EyeWorld Weekly https://t.co/9xD0iqoifq https://t.co/3tPtxwAnj0

    • Mashup Score: 0
      Identifying and handling steroid-induced glaucoma - EyeWorld - 24 day(s) ago

      Steroid-induced glaucoma can present a number of issues, most notably increased IOP. Several ophthalmologists discussed identifying when and why this occurs and how to react to help improve the pressure.

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        Steroid-induced glaucoma can pres¬ent several issues, most notably increased IOP. Rebecca Chen, MD, Malik Y. Kahook, MD, and Robert Noecker, MD, MBA, discuss this condition with EyeWorld https://t.co/vscet8vhuP https://t.co/d6v3mbrNNJ

    • Mashup Score: 0
      Tarsorrhaphy: the cornea’s best friend - EyeWorld - 26 day(s) ago

      Three cornea specialists and one oculoplastics specialist agreed that, in some cases, closing the eyelid with either a permanent or temporary tarsorrhaphy is among the best treatments for corneal healing; the procedure is, in many ways, “the cornea’s best friend.”

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        Three cornea specialists agreed that in some cases, closing the eyelid with either a permanent or temporary tarsorrhaphy is among the best treatments for corneal healing; the procedure is, in many ways, “the cornea’s best friend.” https://t.co/vPgdMDG3vH #EyeWorldMagazine https://t.co/jDoHhgZVka

    • Mashup Score: 1
      Business of Refractive Cataract Surgery heads to Chicago - EyeWorld - 27 day(s) ago

      The second Business of Refractive Cataract Surgery (BRiCS) Summit will take place October 3–5 in Chicago, Illinois, giving a new set of surgeon-implementor teams the opportunity to gain insights and resources to enhance their advanced-technology IOL practice.

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        The Business of Refractive Cataract Surgery (BRiCS) Summit is back! Learn more about this incredible upcoming event in this preview article in #EyeWorld magazine https://t.co/7Mb33sEodH https://t.co/72iVoaxEly

    • Mashup Score: 0
      EyeWorld Weekly, June 6, 2025 - EyeWorld - 1 month(s) ago

      ➤ FDA approves first-in-class DED drop ➤ FDA accepts NDA for topical presbyopia therapy ➤ TFOS DEWS III ➤ Topline results in Phase 3 study evaluating night driving impairment after keratorefractive surgery ➤ IND application submitted for pediatric myopia treatment ➤ Study sheds light on clinical inherited retinal diseases without genetic mutations ➤ ASCRS news and events

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        News of the week: FDA approves first-in-class DED drop, NDA accepted for presbyopia therapy, info on the TFOS DEWS III, and more. Read all about it in EyeWorld Weekly https://t.co/fNELooytSo https://t.co/zTT5Tg9LW4

    • Mashup Score: 0
      Richard Lindstrom, MD, reflects on his history and experience with ASCRS - EyeWorld - 1 month(s) ago

      Richard Lindstrom, MD, has been a member of ASCRS for decades, almost since the Society’s inception, serving in various leadership roles for 40 years. This year, Dr. Lindstrom is stepping down from leadership and will be inducted into the ASCRS Ophthalmology Hall of Fame.

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        Richard Lindstrom, MD, a stalwart ASCRS member, was recently inducted into the ASCRS Ophthalmology Hall of Fame. In this article, he reflects on his history and experience with the Society https://t.co/lKcmGxTHku https://t.co/5NUOx2U9xs

    • Mashup Score: 0
      Pseudoexfoliation glaucoma: management and considerations for ocular procedures - EyeWorld - 1 month(s) ago

      Pseudoexfoliation syndrome is a systemic, age-related disease, with patients needing more frequent monitoring due to an increased risk of developing secondary open angle glaucoma from the condition. Two physicians provided their perspectives on the condition and advice for its identification, management, and considerations for surgery.

      Source: www.eyeworld.org
      Categories: General Medicine News, Ophthalmology
      Tweet Tweets with this article
      • Profile photo of 	ASCRStweets
        ASCRStweets

        Pseudoexfoliation syndrome requires frequent monitoring due to an increased risk of secondary open-angle glaucoma. Kevin Halenda, MD, and Michael Krause, MD, PhD, provide advice for identification, management, and surgical considerations https://t.co/dAbwwGnGry https://t.co/7kuG5LXIz4

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings